| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.81B | -6.6% |
| Cost of Revenue | $6.84B | -6.4% |
| R&D Expense | $17.0M | +6.3% |
| SG&A Expense | $774.0M | -3.9% |
| Operating Income | $1.12B | -4.7% |
| Pre-tax Income | $886.0M | -4.9% |
| Income Tax | $229.0M | +9.0% |
| Net Income | $658.0M | -9.0% |
| EPS (Basic) | $2.16 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $157.0M | -3.1% |
| Accounts Receivable | $621.0M | -13.3% |
| Inventory | $1.75B | +0.0% |
| Current Assets | $2.78B | -2.1% |
| Total Assets | $11.14B | -0.3% |
| Current Liabilities | $1.90B | -26.5% |
| Long-term Debt | $5.05B | -3.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $840.0M | -26.6% |
| Investing Cash Flow | -$342.0M | +66.6% |
| Financing Cash Flow | -$489.0M | -361.3% |
| -8.1% |
| EPS (Diluted) | $2.16 | -7.7% |
| Stockholders' Equity |
| $3.01B |
| +8.3% |